The Chicago Journal

Your Gateway to the Heartbeat of Chicago

Tahir Javed’s Brief Stint as Special Assistant to the Prime Minister of Pakistan: A Diaspora-Driven Reversal

Tahir Javed's Brief Stint as Special Assistant to the Prime Minister of Pakistan: A Diaspora-Driven Reversal
Sourced photo

On October 6th, 2023, Pakistan witnessed a swift and unexpected appointment that would ultimately become a lightning rod for controversy. Tahir Javed, a Pakistani-American, was named as a Special Assistant on Investment to the Prime Minister. However, this appointment was soon met with an overwhelming negative reaction from the Pakistani diaspora, ultimately prompting the government and establishment to reverse their decision. The key driving force behind the controversy stemmed from Tahir Javed’s criminal history, particularly his conviction in 1992 and a subsequent warning in 2017 from the Food and Drug Administration.

The Appointment

Tahir Javed’s appointment as Special Assistant on Investment was seen by some as a potential move to harness his financial expertise and business acumen to drive investment in Pakistan. However, it wasn’t long before his past came under the spotlight, leading to an outcry both within the country and among the Pakistani diaspora.

Criminal History

One of the primary reasons for the negative reaction to Tahir Javed’s appointment was his criminal history. In January 1992, he was convicted of a crime that resulted in a five-year probation period. This past conviction raised concerns among many who questioned his suitability for a high-ranking government position. Criminal records can often have a significant impact on an individual’s eligibility for public office, and the public was quick to raise questions about whether Javed’s appointment met the necessary ethical and legal standards.

FDA Warning

In addition to his prior conviction, Tahir Javed’s association with a warning issued by the Food and Drug Administration (FDA) in July 2017 added to the controversy. The FDA is a key regulatory body responsible for safeguarding public health in the United States. Any warning or action taken by the FDA carries serious implications. Javed’s connection to an FDA warning further fueled doubts about his suitability for a role related to investments and economic policy.

Pakistani Diaspora’s Reaction

The negative reaction was not limited to the borders of Pakistan but echoed within the global Pakistani diaspora. This diaspora, often an influential and vocal community, expressed strong reservations about Tahir Javed’s appointment. They highlighted his criminal record and the FDA warning as compelling reasons for the government to reconsider his role. Social media campaigns, petitions, and open letters were mobilized to voice these concerns, creating substantial pressure on the government.

Reversal of the Decision

Under the weight of growing dissent and public outcry, the government and establishment were compelled to reevaluate the appointment of Tahir Javed on 23rd October 2023. This decision was swift and notable for its responsiveness to public concerns. It demonstrated the significance of public opinion and the role of the diaspora in influencing government decisions.


Tahir Javed’s appointment as Special Assistant to the Prime Minister was short-lived but marked by intense controversy. The negative reaction from the Pakistani diaspora played a pivotal role in urging the government and establishment to reconsider their decision. Tahir Javed’s criminal history and association with an FDA warning proved insurmountable obstacles to his tenure in this influential position. This incident underscores the importance of public scrutiny and the need for governments to be responsive to the concerns of their citizens, even when those citizens are spread across the world in the form of a vocal diaspora. It serves as a reminder that transparency and public trust are essential elements of effective governance, both in Pakistan and beyond.

Share this article


This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of The Chicago Journal.